• OPEN AN ACCOUNT
Indian Indices
Sensex
76,570.35 -373.93
( -0.49%)
Global Indices
Nasdaq
52,794.59 -412.31
(-0.77%)
Dow Jones
7,653.60 -53.54
(-0.69%)
Hang Seng
64,415.54 -1,799.80
(-2.72%)
Nikkei 225
10,761.93 -27.35
(-0.25%)
Forex
USD-INR
95.24 -0.24
(-0.25%)
EUR-INR
110.49 -0.08
(-0.07%)
GBP-INR
128.99 -0.20
(-0.15%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

nilkanth resoures ltd
Alkem Laboratories consolidated net profit declines 22.69% in the March 2026 quarter
May 28,2026
Net profit of Alkem Laboratories declined 22.69% to Rs 236.46 crore in the quarter ended March 2026 as against Rs 305.86 crore during the previous quarter ended March 2025. Sales rose 14.62% to Rs 3603.32 crore in the quarter ended March 2026 as against Rs 3143.75 crore during the previous quarter ended March 2025.

For the full year,net profit rose 6.30% to Rs 2301.80 crore in the year ended March 2026 as against Rs 2165.48 crore during the previous year ended March 2025. Sales rose 13.48% to Rs 14712.27 crore in the year ended March 2026 as against Rs 12964.52 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3603.323143.75 15 14712.2712964.52 13
OPM %14.3612.45 -20.4319.38 -
PBDT663.58508.83 30 3427.782884.19 19
PBT557.82396.34 41 3045.722527.03 21
NP236.46305.86 -23 2301.802165.48 6